Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-alcoholic fatty liver disease: A sign of systemic disease
Isabella Reccia, Kumar Jayant, Chérif Akladios, et al.
Metabolism (2017) Vol. 72, pp. 94-108
Closed Access | Times Cited: 157

Showing 1-25 of 157 citing articles:

Therapeutic targeting of the NRF2 and KEAP1 partnership in chronic diseases
Antonio Cuadrado, Ana I. Rojo, Geoffrey Wells, et al.
Nature Reviews Drug Discovery (2019) Vol. 18, Iss. 4, pp. 295-317
Open Access | Times Cited: 1064
Transcription Factor NRF2 as a Therapeutic Target for Chronic Diseases: A Systems Medicine Approach
Antonio Cuadrado, Gina Manda, Ahmed Hassan, et al.
Pharmacological Reviews (2018) Vol. 70, Iss. 2, pp. 348-383
Open Access | Times Cited: 531
Wnt–β-catenin signalling in liver development, health and disease
María J. Perugorria, Paula Olaizola, Ibone Labiano, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 16, Iss. 2, pp. 121-136
Closed Access | Times Cited: 447
Lipidomic biomarkers and mechanisms of lipotoxicity in non-alcoholic fatty liver disease
Gianluca Svegliati‐Baroni, I. Pierantonelli, Pierangelo Torquato, et al.
Free Radical Biology and Medicine (2019) Vol. 144, pp. 293-309
Closed Access | Times Cited: 191
Components of metabolic syndrome increase the risk of mortality in nonalcoholic fatty liver disease (NAFLD)
Pegah Golabi, Munkhzul Otgonsuren, Leyla de Avila, et al.
Medicine (2018) Vol. 97, Iss. 13, pp. e0214-e0214
Open Access | Times Cited: 177
Prevalence of at‐risk MASH, MetALD and alcohol‐associated steatotic liver disease in the general population
Carolin V. Schneider, Kai Markus Schneider, A. Raptis, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 10, pp. 1271-1281
Closed Access | Times Cited: 18
Small molecule-driven LKB1 deacetylation is responsible for the inhibition of hepatic lipid response in NAFLD
Weiwei Qin, Yu Ding, Wenhao Zhang, et al.
Journal of Lipid Research (2025), pp. 100740-100740
Open Access | Times Cited: 3
Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease
Chrysoula Boutari, Nikolaos Perakakis, Christos S. Mantzoros
Endocrinology and Metabolism (2018) Vol. 33, Iss. 1, pp. 33-33
Open Access | Times Cited: 147
Protective Effects of Licochalcone A Ameliorates Obesity and Non-Alcoholic Fatty Liver Disease Via Promotion of the Sirt-1/AMPK Pathway in Mice Fed a High-Fat Diet
Chian‐Jiun Liou, Yau-Ker Lee, Nai‐Chun Ting, et al.
Cells (2019) Vol. 8, Iss. 5, pp. 447-447
Open Access | Times Cited: 137
Activation of Liver AMPK with PF-06409577 Corrects NAFLD and Lowers Cholesterol in Rodent and Primate Preclinical Models
Ryan M. Esquejo, Christopher T. Salatto, Jake Delmore, et al.
EBioMedicine (2018) Vol. 31, pp. 122-132
Open Access | Times Cited: 121
Obesity and gastrointestinal cancer: the interrelationship of adipose and tumour microenvironments
Jacintha O’Sullivan, Joanne Lysaght, Claire L. Donohoe, et al.
Nature Reviews Gastroenterology & Hepatology (2018) Vol. 15, Iss. 11, pp. 699-714
Closed Access | Times Cited: 118
Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis
K.S. Tølbøl, Maria Nicoline Baandrup Kristiansen, Henrik H. Hansen, et al.
World Journal of Gastroenterology (2018) Vol. 24, Iss. 2, pp. 179-194
Open Access | Times Cited: 115
Non-invasive diagnosis of non-alcoholic steatohepatitis and fibrosis with the use of omics and supervised learning: A proof of concept study
Nikolaos Perakakis, Stergios A. Pοlyzos, Alireza Yazdani, et al.
Metabolism (2019) Vol. 101, pp. 154005-154005
Closed Access | Times Cited: 106
Modeling the Western Diet for Preclinical Investigations
Korry Hintze, Abby D. Benninghoff, Clara E. Cho, et al.
Advances in Nutrition (2018) Vol. 9, Iss. 3, pp. 263-271
Open Access | Times Cited: 92
Low-Dose Levothyroxine Reduces Intrahepatic Lipid Content in Patients With Type 2 Diabetes Mellitus and NAFLD
Eveline Bruinstroop, Rinkoo Dalan, Yang Cao, et al.
The Journal of Clinical Endocrinology & Metabolism (2018) Vol. 103, Iss. 7, pp. 2698-2706
Open Access | Times Cited: 90
Role of Oxidative Stress in Hepatic and Extrahepatic Dysfunctions during Nonalcoholic Fatty Liver Disease (NAFLD)
Andrea González, Camila Huerta-Salgado, Josué Orozco-Aguilar, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-16
Open Access | Times Cited: 78
Links between gut microbiome composition and fatty liver disease in a large population sample
Matti O. Ruuskanen, Fredrik Åberg, Ville Männistö, et al.
Gut Microbes (2021) Vol. 13, Iss. 1
Open Access | Times Cited: 58
Phytochemical gallic acid alleviates nonalcoholic fatty liver disease via AMPK-ACC-PPARa axis through dual regulation of lipid metabolism and mitochondrial function
Jiaxin Zhang, Wenxin Zhang, Li Yang, et al.
Phytomedicine (2022) Vol. 109, pp. 154589-154589
Open Access | Times Cited: 47
The bidirectional immune crosstalk in metabolic dysfunction-associated steatotic liver disease
Keisuke Sawada, Hak‐Jae Chung, Samir Softic, et al.
Cell Metabolism (2023) Vol. 35, Iss. 11, pp. 1852-1871
Open Access | Times Cited: 34
Molecular Changes of Meat Proteins During Processing and Their Impact on Quality and Nutritional Values
Chunbao Li, Anthony Pius Bassey, Guanghong Zhou
Annual Review of Food Science and Technology (2023) Vol. 14, Iss. 1, pp. 85-111
Open Access | Times Cited: 23
Fisetin Protects Against Hepatic Steatosis Through Regulation of the Sirt1/AMPK and Fatty Acid β-Oxidation Signaling Pathway in High-Fat Diet-Induced Obese Mice
Chian‐Jiun Liou, Ciao-Han Wei, Ya-Ling Chen, et al.
Cellular Physiology and Biochemistry (2018) Vol. 49, Iss. 5, pp. 1870-1884
Open Access | Times Cited: 82
Gut inflammation exacerbates hepatic injury in the high-fat diet induced NAFLD mouse: Attention to the gut-vascular barrier dysfunction
Chunwei Cheng, Jun Tan, Wei Qian, et al.
Life Sciences (2018) Vol. 209, pp. 157-166
Closed Access | Times Cited: 71
Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults
Susana A. Palma-Duran, Meropi Kontogianni, Antonis Vlassopoulos, et al.
Metabolism (2018) Vol. 83, pp. 120-127
Open Access | Times Cited: 70
Fucoxanthin attenuates fatty acid-induced lipid accumulation in FL83B hepatocytes through regulated Sirt1/AMPK signaling pathway
Yi-Hsien Chang, Ya-Ling Chen, Wen‐Chung Huang, et al.
Biochemical and Biophysical Research Communications (2017) Vol. 495, Iss. 1, pp. 197-203
Closed Access | Times Cited: 64
Isorhamnetin Alleviates Steatosis and Fibrosis in Mice with Nonalcoholic Steatohepatitis
Munkhzul Ganbold, Yohei Owada, Yusuke Ozawa, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 60
Page 1 - Next Page

Scroll to top